BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29074612)

  • 21. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
    Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
    Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
    Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
    Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
    Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort.
    Xiang B; Zhang X; Liu W; Mao B; Zhao Y; Wang Y; Gong W; Ye H; Li Y; Zhang Z; Yu Y; He M
    Endocrine; 2024 Jun; ():. PubMed ID: 38851643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma.
    Salvatori R; Daly AF; Quinones-Hinojosa A; Thiry A; Beckers A
    Endocrinol Diabetes Metab Case Rep; 2014; 2014():140048. PubMed ID: 25136448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary Disease in
    Bilbao Garay I; Daly AF; Egaña Zunzunegi N; Beckers A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
    Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
    Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma.
    Hu Y; Yang J; Chang Y; Ma S; Qi J
    Exp Ther Med; 2016 Mar; 11(3):1142-1146. PubMed ID: 26998050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoplexy in sporadic pituitary adenomas: a single referral center experience and
    Fialho C; Barbosa MÁ; Lima CHA; Wildemberg LEA; Gadelha MR; Kasuki L
    Arch Endocrinol Metab; 2021 Nov; 65(3):295-304. PubMed ID: 33909377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
    Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
    Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
    Yarman S; Ogret YD; Oguz FS
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
    Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
    Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.